Chondroxide pills 250mg №60

Composition

Pills:
1 pill contains Chondroitin sulfate - 0.25 g;
Excipients: calcium stearate, crospovidone, polyvinylpyrrolidone (povidone), microcrystalline cellulose, Magnesium carbonate basic aqueous (magnesium carbonate) - sufficient amount to obtain a pill weighing 0.48;
30, 60 pcs. packaged.

Chondroxide is a stimulator of tissue regeneration. It has chondrostimulating, regenerating, anti-inflammatory effect.

Chondroxide is involved in the construction of the main substance of cartilage and bone tissue; affects the metabolic processes in hyaline and fibrous cartilage. It inhibits the processes of degeneration (destruction) of cartilage and connective tissue; inhibits enzymes that cause cartilage damage.
The drug stimulates biosynthesis of proteoglycans, promotes the regeneration of the articular sac and the hrastevye surfaces of the joints, increases the production of intra-articular fluid, leads to a decrease in inflammation.
Potentially can prevent the formation of fibrin clots in the synovial and subchondral bloodstream.
Chondroxide slows down the progression of osteoarthritis and osteochondrosis, normalizes metabolism in hyaline tissue, stimulates regeneration (restoration) processes in articular cartilage. At use of the drug Hondroksid&№174; morbidity decreases and mobility of the affected joints improves, at the same time the therapeutic effect remains for a long time after the termination of a course of therapy.

Indications and usage

Treatment and prevention of degenerative-dystrophic diseases of the joints and spine (osteoarthritis, osteochondrosis).

Dosage and administration

Inside, 0.5 g (2 tablets), 2 times a day.
pills are taken with a small amount of water.

The recommended dosage of the initial course is 6 months. It should be borne in mind that the therapeutic effect of the drug lasts for 3-5 months after its cancellation, depending on the location and stage of the disease.If necessary, it is possible to conduct repeated courses of treatment, the duration of which is determined individually.

Contraindications

Hypersensitivity to the drug components, pregnancy and lactation.
Carefully: with bleeding and bleeding tendency.

Side effects
Possible: allergic reactions, nausea, diarrhea.

Special notes

Perhaps increasing the effect of indirect anticoagulants, antiplatelet agents, fibrinolitikov, which requires more frequent monitoring of blood coagulation when used together.

Storage conditions

In a dry, dark place at temperatures up to 20 ° C.
Shelf life - 2 years.

Chondroxide